Antipsychotic medications are powerful pharmacological agents primarily used to manage severe psychiatric conditions such as schizophrenia, bipolar disorder, and severe major depression with psychotic features. In the context of midwifery and maternal mental health, encountering pregnant or postpartum women taking these medications is becoming increasingly common. Midwives must understand that abruptly stopping psychiatric medication during pregnancy carries a very high risk of symptom relapse, which can be devastating for both the mother and her developing baby. Treatment decisions therefore require careful balancing of maternal mental stability against potential fetal drug exposure. Collaborative care involving psychiatrists, obstetricians, and midwives ensures the mother remains stable while minimizing risks to the pregnancy.
Antipsychotic drugs are broadly split into two main generations based on their chemical structure, receptor binding profiles, and side effect tendencies.
The therapeutic action of antipsychotics centers mainly on the brain's neurotransmitters, particularly dopamine and serotonin. In psychotic disorders, certain brain pathways experience overactivity or imbalance.
Typical antipsychotics work by strongly blocking dopamine D2 receptors in the mesolimbic pathway, which successfully subdues hallucinations and delusions. However, blocking dopamine in other pathways, such as the nigrostriatal pathway, leads to unwanted movement side effects. Atypical antipsychotics temper this effect by simultaneously blocking serotonin receptors alongside dopamine receptors, which helps reduce movement side effects while still managing the psychiatric illness.
Nearly all psychotropic medications, including antipsychotics, cross the human placenta to some degree. Because of this, fetal exposure is an inevitable consideration during intrauterine treatment. While most antipsychotics are not classified as major structural teratogens—meaning they rarely cause gross physical birth defects—late pregnancy exposure can still affect the newborn. Neonates delivered by mothers taking antipsychotics close to term may experience adaptation difficulties, respiratory depression, or mild withdrawal symptoms. Midwives should anticipate the need for newborn assessment at birth, ensuring pediatric staff are aware of the maternal medication history.
Monitoring women on antipsychotics requires vigilance for both acute and chronic adverse effects. Typical agents frequently cause extrapyramidal symptoms, including muscle stiffness, tremors, and restlessness. Atypical agents are notorious for metabolic changes, such as rapid weight gain, elevated blood glucose, and dyslipidemia. Midwives play a key role in routine antenatal care by tracking maternal weight gain, checking blood pressure, and reviewing urinalysis results for glucose. Any signs of excessive sedation, severe restlessness, or unmanaged tremors must be reported promptly to the prescribing physician for dose adjustment.
Many mothers with psychiatric conditions wish to breastfeed, and postpartum stability is vital for successful mother-infant bonding. Most antipsychotics pass into breast milk in small amounts. Medications like olanzapine and quetiapine are generally considered relatively safe during lactation because infant serum levels remain very low. However, breastfeeding infants must be monitored for excessive sleepiness, poor feeding, or inadequate weight gain. The midwife supports the mother by encouraging skin-to-skin contact, observing infant feeding patterns closely, and reassuring her when medication use aligns safely with lactation guidelines.
A comprehensive midwifery care plan for a woman taking antipsychotics integrates mental health support with standard antenatal and postpartum care. Education empowers the patient and her family to recognize early signs of mental health deterioration. Midwives must reinforce that medication should never be stopped without consulting a doctor. Care plans should also incorporate nutritional counseling to address metabolic risks, referrals to mental health support groups, and a clear postpartum follow-up schedule to catch mood shifts early.